Position in SGMOQ
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$176,620
-$119,251 QoQ
Shares Held
706,481
+0.3% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Derivatives in SGMOQ
reported options exposure · as of Mar 31, 2020CallValue
$2,000
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in SGMOQ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $176,620 | 706,481 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $295,871 | 704,456 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $498,551 | 744,106 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $402,174 | 744,768 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $502,037 | 760,663 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $771,959 | 756,823 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $689,977 | 793,078 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $285,232 | 792,313 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $528,154 | 788,290 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $427,253 | 791,210 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $685,884 | 1,143,140 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,503,924 | 1,156,865 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,814,792 | 1,031,132 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,237,208 | 1,030,958 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,693,432 | 1,161,925 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,833,586 | 1,167,533 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $6,155,793 | 1,059,517 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,078,620 | 943,816 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $272,246 | 30,216 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $422,493 | 35,296 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $419,015 | 33,441 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $577,335 | 36,985 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $366,045 | 38,735 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $364,949 | 40,731 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $276,286 | 43,373 | Shares | Sole | 2020-05-21 | |
| 2020-03-31 | $2,000 | 20,000 | Call | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||